| Gene symbol | MSLN | Synonyms | MPF, SMRP | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.3 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | mesothelin | ||||
| GTO ID | GTC3509 |
| Trial ID | NCT05944185 |
| Disease | Solid Tumor |
| Altered gene | MSLN |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | αPD1-MSLN-CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Not Recruiting |
| Title | Phase I/II Study of αPD1-MSLN-CAR T Cells in MSLN-positive Advanced Solid Tumors |
| Year | 2023 |
| Country | China |
| Company sponsor | Shanghai Cell Therapy Group Co.,Ltd |
| Other ID(s) | BZDS1901-CTP-I/II-01 |
| Cohort 1 | |||||||
|
|||||||